Supplements
magnesium treats chronic constipation
In plain terms: Does magnesium relieve constipation?
Part of: 🧪 magnesium
Yes—magnesium oxide is a genuine osmotic laxative with solid trial support, one of magnesium's best-established uses.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Magnesium oxide is a genuine osmotic laxative and one of magnesium's best-supported uses: SR/MA and RCT evidence show it improves stool frequency/consistency in chronic idiopathic constipation, and it appears in dietary constipation guidance (albeit under-emphasized). This is a mechanism-backed, trial-supported effect — distinct from the softer supplement claims.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Morishita D, Tomita T, Mori S, Kimura T, Oshima T, Fukui H, Miwa H 2021 · Am J Gastroenterol | RCT | supports | moderate | Double-blind placebo-controlled RCT: magnesium oxide effective vs placebo for chronic idiopathic constipation (compared against senna). |
| Dimidi E, van der Schoot A, Barrett K, Farmer AD, Lomer MC, Scott SM, Whelan K 2025 · J Hum Nutr Diet | meta-analysis | supports | high | BDA evidence-based dietary guideline: magnesium oxide among supported strategies for chronic constipation. |
| van der Schoot A, Creedon A, Whelan K, Dimidi E 2023 · Neurogastroenterol Motil | meta-analysis | supports | moderate | SR/MA of food/vitamin/mineral supplements for chronic constipation: magnesium oxide effective for stool output/symptoms. |
| Dimidi E, van der Schoot A, Barrett K, Farmer AD, Lomer MC, Scott SM, Whelan K 2025 · Neurogastroenterology and motility | meta-analysis | supports | high | BDA guideline: 4 systematic reviews/MAs, 75 RCTs total; 5 of 59 recommendation statements specifically address magnesium oxide as dietary supplement for CC |
| Hsiao PJ, Tsou LL, Yang CC, Huang LY, Wang RL, Chan JS, Wu KL, Kao YH, Chou CL 2026 · International journal of medical sciences | observational | tested-null | moderate | Taiwan cohort, non-dialysis CKD, MgO users vs non-users: matched aHR AKI 37.0, AKD 6.26, ESRD 3.13, arrhythmia 2.06, MI 1.86 (dose-response by CKD stage) |
| Dimidi E 2025 · Proc Nutr Soc | observational | supports | low | Evidence review of dietary management of chronic constipation: MgO among strategies with supporting RCT/MA evidence, though under-recommended in guidelines. |
| Kessoku T, Ishihara Y, Takahashi K, Dang TH, Ohira M, Horiuchi M, Shibata C, Uchida A, Toriumi Y, Misawa N, Ohkubo H, Imajo K, Oyamada S, Iwasaki T, Kurihashi T, Manabe N, Abe T, Nakajima A 2025 · Neurogastroenterology and motility | observational | mixed | moderate | MgO(n=30) vs elobixibat(n=43) in CC: LODD improved 33% vs 65% (p<0.001); FDDV −0.1 vs 35mL; STC→NTC shift 37% vs 87% (p=0.003), EXB>MgO |
| Yoneda H, Tomita T, Kitano T, Morishita D, Kodani M, Nishii N, Sei H, Eda H, Sato T, Kawai M, Yokoyama Y, Igeta M, Okugawa T, Fukui H, Shinzaki S 2026 · Neurogastroenterology and motility | RCT | mixed | low | n=40 healthy, Mg-rich mineral water 1L/day 14d vs soft water: BSFS ↑ wk1&wk2 (p<0.05), ↑ SBM/CSBM freq, no safety concerns |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.